SlideShare a Scribd company logo
Khure Health
Clinical Intelligence & Decision Support for Rare & Complex Conditions
Mission:
To help physicians save lives and end the suffering of rare and
complex disease patients and their families through the use of
advanced AI.
How:
• Harness the power of AI through a powerful clinical
decision-support tool
• Help physicians put the vast amounts of data sitting idle in
their EMR to good use for proactive, personalized patient
care
Khure Health’s Clinical Intelligence Platform
Instantly Screen EMR to Identify High-Risk Patients
• Rare Disease focused: AI-enabled algorithms to instantly
identify at risk patients and clinical support to help optimize
care pathways
• Instant In-Visit Screen: Screen a challenging patient
against all available pathologies instantly
• Advanced Education: Education material and accredited
programs available
• Participate in Clinical Research: algorithms based on
protocols, instantly identify High Fit patients for trials.
• Free to Canadian physicians as a result of our work with
Patient Advocacy Groups, Pharma, CROs and Academia
Khure Health’s Clinical Intelligence Platform
Instant Results Showing Patients at Risk
• Click-of-a-button complete practice reflective
• Instant summary results
• Patients grouped into risk categories:
o High-risk
o At Risk
o Flagged
Khure Health’s Clinical Intelligence Platform
Showing Patient Specific Clinical Criteria Indicating Risk
• Full EMR analysis of medications,
labs, reports, symptoms, longitudinal
history, physician notes
• Product & Service: Khure team
provides clinical care pathway support
for rare conditions and platform
navigation
• Streamlined Workflows: pre-
populated referral forms and lab
requisitions
Pathologies currently on the Khure Health platform
78 and counting (with integration of chronic conditions in development)
1. Aagenaes Syndrome
2. Acquired Hemophilia A
3. Adult Dermatomyositis
4. Adult ITP (Idiopathic Thrombocytopenic Purpura)
5. Adult Onset Still's Disease
6. Adult Polymyositis
7. Alpha Thalassemia
8. Ankylosing Spondylitis
9. Aquired Pure Red Cell Aplasia
10. Atypical Hemolytic Uremic Syndrome
11. Autosomal Dominant Polycystic Kidney Disease
12. Beta Thalassemia
13. Chronic Idiopathic Urticaria
14. Cushing's Syndrome
15. Diabetic Macular Edema
16. Essential Thrombocythemia
17. Fabry's Disease
18. Gaucher's Disease
19. Giant Cell Arteritis
20. hATTR Amyloidosis
21. Henoch Schonlein Purpura
22. Hepatitis C Virus (HCV)
23. Hepatopulmonary Syndrome
24. Hereditary Angiodema (HAE)
25. Hereditary Elliptocytosis
26. Hereditary Spherocytosis
27. HHRH (Hereditary Hypophosphatemic Rickets with Hypercalciuria)
28. Hunter Syndrome
29. Hurlers Disease
30. Hypophophatasia
31. Hypophosphatemia X-Linked
32. Juvenile Dermatomyositis
33. Juvenile ITP (Idiopathic Thrombocytopenic Purpura)
34. Juvenile Polymyositis
35. Kawasaki Disease
36. Loeyz-Dietz Syndrome
37. Multiple Myeloma
38. Mutli-focal Motor Neuropathy
39. Myelofibrosis
40. Neuroblastoma
41. Neuromyelitis Optica Spectrum Disorder
42. Paroxysmal Nocturnal Hemoglobinuria
43. Pompe Disease
44. PPP (Palmoplantar Pustular Psoriasis)
45. Primary Biliary Cholangitis
46. Pulmonary Arterial Hypertension
47. Severe Allergic Asthma
48. Severe Eosinophilic Asthma
49. Sideroblastic Anemia
50. Thrombotic Thrombocytopenic Purpura
51. Typical Hemolytic Uremic Syndrome
52. Von Willebrand’s
53. AA Amyloidosis
54. Atrial Fibrillation
55. Bernard-Soulier Syndrome
56. Brugada Syndrome
57. Cold Agglutinin Disease
58. Ebstein anomaly
59. Eisenmenger syndrome
60. Fanconi Anemia
61. Glanzmann Thrombasthenia
62. Immune Thrombocytopenia Purpura (ITP)
63. Marfans Syndrome
64. Myelodysplastic Syndrome
65. Non-ischemic pediatric cardiomyopathy
66. Patent ductus arteriosus
67. Polycythemia Vera
68. Psoariatic Arthritis
69. Severe Plaque Psoriasis
70. Shprintzen-Goldberg syndrome
71. Sickle Cell Anemia
72. ALS
73. nmCRPC
74. Transthretin Amyloid Cardiomyopathy
75. Recurrent Fever Syndromes
76. Castlemen's Disorder
77. Neiman Pick
78. Primary Sclerosing Cholangitis
Pathologies on the Khure Health Platform
100 by February 28, 2022 (International Rare Disease Day)
79. Rheumatoid Arthritis
80. Secondary hyperparathyroidism
81. Spinal Muscular Atrophy
82. Long-Chain Fatty Acid Oxidation Disorders
83. Anaplastic lymphoma kinase (ALK)-positive metastatic Non-small cell lung cancer
84. Best Vitelliform Macular Dystrophy
85. Budd-Chiari Syndrome
86. Cerebral Adrenoleukodystrophy
87. Cone Dystrophy
88. Cystic Fibrosis
89. Emphysema - severe hereditary deficiency of alpha1-PI alpha1-antitrypsin deficiency)
90. Endometrosis
91. Guillan-Barre Syndrome
92. Hemi-Plegic Migraines
93. Hepatopulmonary Syndrome
94. Juvenile idiopathic arthritis
95. Metastatic Colorectal Cancer
96. Morquio syndrome
97. Multiple Sclerosis (Remitting-Relapsing)
98. Myasthenia gravis
99. Narcolepsy
100. B-cell precursor acute lymphoblastic leukemia (relapsed or refractory)
By Specialty Total:100
1
1
1
2
2
3
3
4
5
5
6
6
10
13
14
24
Immunology
Obstetrics & Gynaecology
Urology
Dermatology
Gastroenterology
Nephrology
Ophthamology
Pulmonology
Endocrinology
Hepatology
Metabolic
Oncology
Neurology
Cardiology
Rheumatology
Hematology

More Related Content

Similar to Don Watts: Rare Disease Drug Strategy Webinar

Rare Disease Day Conference: From Draft to Action Plan
Rare Disease Day Conference: From Draft to Action PlanRare Disease Day Conference: From Draft to Action Plan
Rare Disease Day Conference: From Draft to Action Plan
Canadian Organization for Rare Disorders
 
Transforming Health Care In Africa
Transforming Health Care In Africa Transforming Health Care In Africa
Transforming Health Care In Africa
Jacques Kpodonu,MD
 
CharakMemorialhospitalServices.pptx
CharakMemorialhospitalServices.pptxCharakMemorialhospitalServices.pptx
CharakMemorialhospitalServices.pptx
CHARAK MEMORIAL HOSPITAL PVT. LTD .
 
180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)
SMBBV
 
Hiv and periodontium
Hiv and periodontiumHiv and periodontium
Hiv and periodontium
Dandu Prasad Reddy
 
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
jangeissler
 
Opening Keynote “Population Management: The CareMore Experience" David Ramire...
Opening Keynote “Population Management: The CareMore Experience" David Ramire...Opening Keynote “Population Management: The CareMore Experience" David Ramire...
Opening Keynote “Population Management: The CareMore Experience" David Ramire...
Health IT Conference – iHT2
 
Rational use of drugs -1
Rational use of drugs -1Rational use of drugs -1
Rational use of drugs -1
Muhammad Saalim
 
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
Animikh Ray
 
Value Added Solutions for Orphan Disease Trials
Value Added Solutions for Orphan Disease TrialsValue Added Solutions for Orphan Disease Trials
Value Added Solutions for Orphan Disease Trials
MNI08072014
 
Review of Uveitis
Review of UveitisReview of Uveitis
Review of Uveitis
Visionary Ophthamology
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
jangeissler
 
Healthcare07
Healthcare07Healthcare07
Healthcare07
Chris Willmott
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
Nancy126144
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
SuriaKumar4
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
naomikibithe1
 
std-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfddstd-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfdd
Ralphjeanomurillo
 
sexually transmitted diseases-module.ppt
sexually transmitted diseases-module.pptsexually transmitted diseases-module.ppt
sexually transmitted diseases-module.ppt
RODELAZARES3
 
Future of healthcare
Future of healthcareFuture of healthcare
Future of healthcare
Kerry Richardson
 
HIV Primary Care
HIV Primary CareHIV Primary Care
HIV Primary Care
tjsiddiqui
 

Similar to Don Watts: Rare Disease Drug Strategy Webinar (20)

Rare Disease Day Conference: From Draft to Action Plan
Rare Disease Day Conference: From Draft to Action PlanRare Disease Day Conference: From Draft to Action Plan
Rare Disease Day Conference: From Draft to Action Plan
 
Transforming Health Care In Africa
Transforming Health Care In Africa Transforming Health Care In Africa
Transforming Health Care In Africa
 
CharakMemorialhospitalServices.pptx
CharakMemorialhospitalServices.pptxCharakMemorialhospitalServices.pptx
CharakMemorialhospitalServices.pptx
 
180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)180927 presentation enzyre waander van heerde (smb hv meeting)
180927 presentation enzyre waander van heerde (smb hv meeting)
 
Hiv and periodontium
Hiv and periodontiumHiv and periodontium
Hiv and periodontium
 
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...European Cancer Patient Advocacy: Introduction to the community, key stakehol...
European Cancer Patient Advocacy: Introduction to the community, key stakehol...
 
Opening Keynote “Population Management: The CareMore Experience" David Ramire...
Opening Keynote “Population Management: The CareMore Experience" David Ramire...Opening Keynote “Population Management: The CareMore Experience" David Ramire...
Opening Keynote “Population Management: The CareMore Experience" David Ramire...
 
Rational use of drugs -1
Rational use of drugs -1Rational use of drugs -1
Rational use of drugs -1
 
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
26 Oct 2017 Genetics and precision medicine Milano Cornel.ppt
 
Value Added Solutions for Orphan Disease Trials
Value Added Solutions for Orphan Disease TrialsValue Added Solutions for Orphan Disease Trials
Value Added Solutions for Orphan Disease Trials
 
Review of Uveitis
Review of UveitisReview of Uveitis
Review of Uveitis
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 
Healthcare07
Healthcare07Healthcare07
Healthcare07
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
std-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfddstd-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfdd
 
sexually transmitted diseases-module.ppt
sexually transmitted diseases-module.pptsexually transmitted diseases-module.ppt
sexually transmitted diseases-module.ppt
 
Future of healthcare
Future of healthcareFuture of healthcare
Future of healthcare
 
HIV Primary Care
HIV Primary CareHIV Primary Care
HIV Primary Care
 

More from Canadian Organization for Rare Disorders

Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemWebinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Canadian Organization for Rare Disorders
 
CORD-RQMO: English Slides
CORD-RQMO: English Slides CORD-RQMO: English Slides
CORD-RQMO: English Slides
Canadian Organization for Rare Disorders
 
CORD-RQMO: French Slides
CORD-RQMO: French SlidesCORD-RQMO: French Slides
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Canadian Organization for Rare Disorders
 
Day 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela GavinDay 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela Gavin
Canadian Organization for Rare Disorders
 
Day 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORDDay 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORD
Canadian Organization for Rare Disorders
 
Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease  & Drug Access Pathway Day 2: Rare Disease  & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway
Canadian Organization for Rare Disorders
 
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkDay 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Canadian Organization for Rare Disorders
 
Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel
Canadian Organization for Rare Disorders
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Canadian Organization for Rare Disorders
 
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Canadian Organization for Rare Disorders
 
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of OttawaDay 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Canadian Organization for Rare Disorders
 
Day 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTipsDay 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTips
Canadian Organization for Rare Disorders
 
Day 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEODay 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEO
Canadian Organization for Rare Disorders
 
Day 1: INFORM RARE
Day 1: INFORM RAREDay 1: INFORM RARE
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Canadian Organization for Rare Disorders
 
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Canadian Organization for Rare Disorders
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Canadian Organization for Rare Disorders
 
Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD
Canadian Organization for Rare Disorders
 
Day 1: Network of Centres of Excellence
Day 1:  Network of Centres of ExcellenceDay 1:  Network of Centres of Excellence
Day 1: Network of Centres of Excellence
Canadian Organization for Rare Disorders
 

More from Canadian Organization for Rare Disorders (20)

Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease EcosystemWebinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
Webinar: Investing $1.5b in A Sustainable Rare Disease Ecosystem
 
CORD-RQMO: English Slides
CORD-RQMO: English Slides CORD-RQMO: English Slides
CORD-RQMO: English Slides
 
CORD-RQMO: French Slides
CORD-RQMO: French SlidesCORD-RQMO: French Slides
CORD-RQMO: French Slides
 
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
Webinar: PMPRB NEW Guidelines and Impact on Rare Diseases
 
Day 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela GavinDay 1: NORD Centres of Excellence - Pamela Gavin
Day 1: NORD Centres of Excellence - Pamela Gavin
 
Day 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORDDay 1: IAM RARE: Pamela Gavin, NORD
Day 1: IAM RARE: Pamela Gavin, NORD
 
Day 2: Rare Disease & Drug Access Pathway
Day 2: Rare Disease  & Drug Access Pathway Day 2: Rare Disease  & Drug Access Pathway
Day 2: Rare Disease & Drug Access Pathway
 
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research NetworkDay 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
Day 2: Thierry Lacaze-Masmonteil, Maternal Infant Child Youth Research Network
 
Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel Dar 2: Patient Engagement and Patient Empowerment Panel
Dar 2: Patient Engagement and Patient Empowerment Panel
 
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of ManitobaDay 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
Day 2: Cheryl Greenberg, Children's Hospital Research Institute of Manitoba
 
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
Day 1: INFORM RARE: Beth Potter, Alexandra Wyatt, Pranesh Chakraborty, Monica...
 
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of OttawaDay 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
Day 1: Newborn Screening: Pranesh Chakraborty, University of Ottawa
 
Day 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTipsDay 1: Phenotypes: Orion Buske, PhenoTips
Day 1: Phenotypes: Orion Buske, PhenoTips
 
Day 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEODay 1: Genomic Sequencing: Kym Boycott, CHEO
Day 1: Genomic Sequencing: Kym Boycott, CHEO
 
Day 1: INFORM RARE
Day 1: INFORM RAREDay 1: INFORM RARE
Day 1: INFORM RARE
 
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
Day 1 : Canadian Neuromuscular Network, Western University - Craig Campbell, ...
 
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
Day 1: Rare Disease Research Network and National Children’s Hospital - Marsh...
 
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDISDay 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
Day 1: WHO-RDI Global Rare Disease Network - Matt Bolz-Johnson, EURORDIS
 
Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD
 
Day 1: Network of Centres of Excellence
Day 1:  Network of Centres of ExcellenceDay 1:  Network of Centres of Excellence
Day 1: Network of Centres of Excellence
 

Recently uploaded

一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
gjsma0ep
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
Pupayumnam1
 
leprosy Case detection and diagnosis.pptx
leprosy Case detection and diagnosis.pptxleprosy Case detection and diagnosis.pptx
leprosy Case detection and diagnosis.pptx
habtegirma
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
Know Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdfKnow Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdf
Dr. Sujit Chatterjee CEO Hiranandani Hospital
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
priyabhojwani1200
 
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptxCAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
Nursing Station
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
Lift Ability
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
blessyjannu21
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
SamboGlo
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
MatSouthwell1
 

Recently uploaded (20)

一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
 
Sexual Disorders.gender identity disorderspptx
Sexual Disorders.gender identity  disorderspptxSexual Disorders.gender identity  disorderspptx
Sexual Disorders.gender identity disorderspptx
 
leprosy Case detection and diagnosis.pptx
leprosy Case detection and diagnosis.pptxleprosy Case detection and diagnosis.pptx
leprosy Case detection and diagnosis.pptx
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
Know Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdfKnow Latest Hiranandani Hospital Powai News.pdf
Know Latest Hiranandani Hospital Powai News.pdf
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COMHUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM
 
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptxCAPNOGRAPHY and CAPNOMETRY/ ETCO2  .pptx
CAPNOGRAPHY and CAPNOMETRY/ ETCO2 .pptx
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
COLOUR CODING IN THE PERIOPERATIVE NURSING PRACTICE.
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
 

Don Watts: Rare Disease Drug Strategy Webinar

  • 1.
  • 2. Khure Health Clinical Intelligence & Decision Support for Rare & Complex Conditions Mission: To help physicians save lives and end the suffering of rare and complex disease patients and their families through the use of advanced AI. How: • Harness the power of AI through a powerful clinical decision-support tool • Help physicians put the vast amounts of data sitting idle in their EMR to good use for proactive, personalized patient care
  • 3. Khure Health’s Clinical Intelligence Platform Instantly Screen EMR to Identify High-Risk Patients • Rare Disease focused: AI-enabled algorithms to instantly identify at risk patients and clinical support to help optimize care pathways • Instant In-Visit Screen: Screen a challenging patient against all available pathologies instantly • Advanced Education: Education material and accredited programs available • Participate in Clinical Research: algorithms based on protocols, instantly identify High Fit patients for trials. • Free to Canadian physicians as a result of our work with Patient Advocacy Groups, Pharma, CROs and Academia
  • 4. Khure Health’s Clinical Intelligence Platform Instant Results Showing Patients at Risk • Click-of-a-button complete practice reflective • Instant summary results • Patients grouped into risk categories: o High-risk o At Risk o Flagged
  • 5. Khure Health’s Clinical Intelligence Platform Showing Patient Specific Clinical Criteria Indicating Risk • Full EMR analysis of medications, labs, reports, symptoms, longitudinal history, physician notes • Product & Service: Khure team provides clinical care pathway support for rare conditions and platform navigation • Streamlined Workflows: pre- populated referral forms and lab requisitions
  • 6. Pathologies currently on the Khure Health platform 78 and counting (with integration of chronic conditions in development) 1. Aagenaes Syndrome 2. Acquired Hemophilia A 3. Adult Dermatomyositis 4. Adult ITP (Idiopathic Thrombocytopenic Purpura) 5. Adult Onset Still's Disease 6. Adult Polymyositis 7. Alpha Thalassemia 8. Ankylosing Spondylitis 9. Aquired Pure Red Cell Aplasia 10. Atypical Hemolytic Uremic Syndrome 11. Autosomal Dominant Polycystic Kidney Disease 12. Beta Thalassemia 13. Chronic Idiopathic Urticaria 14. Cushing's Syndrome 15. Diabetic Macular Edema 16. Essential Thrombocythemia 17. Fabry's Disease 18. Gaucher's Disease 19. Giant Cell Arteritis 20. hATTR Amyloidosis 21. Henoch Schonlein Purpura 22. Hepatitis C Virus (HCV) 23. Hepatopulmonary Syndrome 24. Hereditary Angiodema (HAE) 25. Hereditary Elliptocytosis 26. Hereditary Spherocytosis 27. HHRH (Hereditary Hypophosphatemic Rickets with Hypercalciuria) 28. Hunter Syndrome 29. Hurlers Disease 30. Hypophophatasia 31. Hypophosphatemia X-Linked 32. Juvenile Dermatomyositis 33. Juvenile ITP (Idiopathic Thrombocytopenic Purpura) 34. Juvenile Polymyositis 35. Kawasaki Disease 36. Loeyz-Dietz Syndrome 37. Multiple Myeloma 38. Mutli-focal Motor Neuropathy 39. Myelofibrosis 40. Neuroblastoma 41. Neuromyelitis Optica Spectrum Disorder 42. Paroxysmal Nocturnal Hemoglobinuria 43. Pompe Disease 44. PPP (Palmoplantar Pustular Psoriasis) 45. Primary Biliary Cholangitis 46. Pulmonary Arterial Hypertension 47. Severe Allergic Asthma 48. Severe Eosinophilic Asthma 49. Sideroblastic Anemia 50. Thrombotic Thrombocytopenic Purpura 51. Typical Hemolytic Uremic Syndrome 52. Von Willebrand’s 53. AA Amyloidosis 54. Atrial Fibrillation 55. Bernard-Soulier Syndrome 56. Brugada Syndrome 57. Cold Agglutinin Disease 58. Ebstein anomaly 59. Eisenmenger syndrome 60. Fanconi Anemia 61. Glanzmann Thrombasthenia 62. Immune Thrombocytopenia Purpura (ITP) 63. Marfans Syndrome 64. Myelodysplastic Syndrome 65. Non-ischemic pediatric cardiomyopathy 66. Patent ductus arteriosus 67. Polycythemia Vera 68. Psoariatic Arthritis 69. Severe Plaque Psoriasis 70. Shprintzen-Goldberg syndrome 71. Sickle Cell Anemia 72. ALS 73. nmCRPC 74. Transthretin Amyloid Cardiomyopathy 75. Recurrent Fever Syndromes 76. Castlemen's Disorder 77. Neiman Pick 78. Primary Sclerosing Cholangitis
  • 7. Pathologies on the Khure Health Platform 100 by February 28, 2022 (International Rare Disease Day) 79. Rheumatoid Arthritis 80. Secondary hyperparathyroidism 81. Spinal Muscular Atrophy 82. Long-Chain Fatty Acid Oxidation Disorders 83. Anaplastic lymphoma kinase (ALK)-positive metastatic Non-small cell lung cancer 84. Best Vitelliform Macular Dystrophy 85. Budd-Chiari Syndrome 86. Cerebral Adrenoleukodystrophy 87. Cone Dystrophy 88. Cystic Fibrosis 89. Emphysema - severe hereditary deficiency of alpha1-PI alpha1-antitrypsin deficiency) 90. Endometrosis 91. Guillan-Barre Syndrome 92. Hemi-Plegic Migraines 93. Hepatopulmonary Syndrome 94. Juvenile idiopathic arthritis 95. Metastatic Colorectal Cancer 96. Morquio syndrome 97. Multiple Sclerosis (Remitting-Relapsing) 98. Myasthenia gravis 99. Narcolepsy 100. B-cell precursor acute lymphoblastic leukemia (relapsed or refractory) By Specialty Total:100 1 1 1 2 2 3 3 4 5 5 6 6 10 13 14 24 Immunology Obstetrics & Gynaecology Urology Dermatology Gastroenterology Nephrology Ophthamology Pulmonology Endocrinology Hepatology Metabolic Oncology Neurology Cardiology Rheumatology Hematology